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Dermatological malignancy is the commonest form of cancer in the United
Kingdom.1 Basal cell carcinoma accounts for approximately 80% of all non-
melanocytic tumours, with a similar percentage affecting the head and neck.2
Tumour growth patterns are variable in this condition,3 with most interest
focusing on 'rodent ulcers' affecting the head and neck. Little is known about the
inherent biological behaviour of truncal basaliomas.4 We present a case of a
giant exophytic basal cell carcinoma affecting the trunk, which presented with
profound anaemia and generalised debility.
CASE REPORT. A 50-year-old male was referred to our surgical unit with a
tumour mass on the left anterolateral chest wall which had been present for at
least 12 years. For two months prior to this, bleeding and a foul smell from the
lesion had caused him social embarrassment. He also complained of extreme
lassitude, palpitations, dyspnoea on exertion; he had lost two stones in weight,
despite having a normal appetite and well-balanced diet. On examination the
patient was pyrexic (38-5°C) and had signs of marked weight loss and of
anaemia. He had sinus tachycardia, but no sign of cardiac or respiratory
embarrassment. There was a mobile, ulcerated exophytic tumour 15 x 15 cm on
his left anterior chest wall (Figure), which was superficially necrotic, ulcerated
and bleeding. There was no evidence of regional lymphadenopathy or systemic
dissemination of this tumour. The patient was of retiring disposition and reluctant
to volunteer information. Hisaffectwasconsistently incongruous; however, when
challenged he admitted to having a deep-seated fear of cancer. Bacterial swabs
grew a heavy mixed population of E.Coli, pseudomonas and bacteroides spp.
Haematological investigation confirmed a microcytic anaemia (Hb 7-0 g/dl,
MCV 64-4 fl, MCHC 27 g/dl, WCC 4-5 x 109/1, platelets 408 x 109/1) and
hypoalbuminaemia (19 g/dl) with a rise in the serum globulin fraction to 49 g/dl
(normal range 20-37). The ESR was 85 mm/hr. Radiological investigations
were within normal limits.
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Figure. Tumour mass removed from the chest wall.
The tumour was widely excised and a split skin graft applied to the defect. He
made an uncomplicated postoperative recovery and was discharged after ten
days. At follow-up his condition had improved, he had recovered one stone in
weight; all haematological parameters had returned to normal one year post-
operatively. Histopathological analysis revealed a giant exophytic basal cell
carcinoma with no evidence of malignant squamous elements. The lesion had
been entirely excised with clear margins and there was no evidence of invasion
beyond the interface of the reticular dermis and subcutis. Despite a very mature
blood supply, areas of this tumour were necrotic and heavily contaminated.
DISCUSSION
Only 4% of all basal cell carcinomas occur on thetrunk,2 most being superficially
erosive in character.5 The disease process is usually terminated in the early
stages6 and it is rare nowadays to see the complete natural history. Over 200
cases of metastasising basal cell carcinomas have been reported to date, and of
these 16-5% were primary truncal.7 It is generally felt that metastatic basal cell
carcinomas originate from large tumours present for may years.8
Giant exophytic basal cell carcinomas are very uncommon. No other cases
presenting with anaemia have been recorded. Controversy remains over the
malignant potential and immunological effects seen in this type of lesion.4 In the
present case, which was allowed to follow its natural course for over 12 years, we
could detect no evidence of metastatic spread, despite the obvious systemic
effects of the tumour through anaemia and debilitating chronic sepsis.
The lesion had ulcerated and bled persistently fortwo months prior to admission.
Although blood loss was the most likely cause of the anaemia, it is possible that
chronic sepsis with bone marrow suppression and non-metastatic biological
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effects of the tumour may have contributed to its development. These secondary
sequelae were clinically misleading and consequently did not reflect the indolent
neoplastic potential of this lesion.
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